Probe has recently successfully completed its TSB funded NEEDS grant. This project targeted the development and production of a prototype of Probe’s patented NanoEye® monitoring device for neonates and paediatrics.
Probe’s signs MicroEye®- based continuous glucose monitoring systems development deal with Czech BVT Technologies.
Probe is pleased to announce that it has supplied MicroEye to Department of Clinical Pharmacy, Isala in Zwolle, Netherlands as part of a study to monitor blood and tissue levels of flucloxacillin in patients with a staphylococcus aureus bacteremia.
Probe has entered into an agreement with Aston University to assist with new application research and analysis.
Probe Scientific has been awarded funds under the SMEE scheme for a short term study at Coventry University.